Summary
Global Markets Direct’s, ‘ProMetic Life Sciences Inc. - Product Pipeline Review - 2016’, provides an overview of the ProMetic Life Sciences Inc.’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by ProMetic Life Sciences Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of ProMetic Life Sciences Inc.
- The report provides overview of ProMetic Life Sciences Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses ProMetic Life Sciences Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features ProMetic Life Sciences Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate ProMetic Life Sciences Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for ProMetic Life Sciences Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding ProMetic Life Sciences Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
ProMetic Life Sciences Inc. Snapshot 5
ProMetic Life Sciences Inc. Overview 5
Key Information 5
Key Facts 5
ProMetic Life Sciences Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
ProMetic Life Sciences Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
ProMetic Life Sciences Inc. - Pipeline Products Glance 13
ProMetic Life Sciences Inc. - Late Stage Pipeline Products 13
Phase III Products/Combination Treatment Modalities 13
ProMetic Life Sciences Inc. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
ProMetic Life Sciences Inc. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
ProMetic Life Sciences Inc. - Drug Profiles 17
immune globulin (human) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
plasminogen (human) 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PBI-4050 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
alpha-1 proteinase inhibitor (human) 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
C1 esterase inhibitor (human) 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
PBI-4419 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
PBI-4425 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
PBI-4547 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
plasminogen (recombinant) 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
ProMetic Life Sciences Inc. - Pipeline Analysis 28
ProMetic Life Sciences Inc. - Pipeline Products by Target 28
ProMetic Life Sciences Inc. - Pipeline Products by Route of Administration 29
ProMetic Life Sciences Inc. - Pipeline Products by Molecule Type 30
ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action 31
ProMetic Life Sciences Inc. - Recent Pipeline Updates 32
ProMetic Life Sciences Inc. - Dormant Projects 38
ProMetic Life Sciences Inc. - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 41
Disclaimer 42
List of Tables
ProMetic Life Sciences Inc., Key Information 5
ProMetic Life Sciences Inc., Key Facts 5
ProMetic Life Sciences Inc. - Pipeline by Indication, 2016 7
ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2016 9
ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2016 10
ProMetic Life Sciences Inc. - Partnered Products in Pipeline, 2016 11
ProMetic Life Sciences Inc. - Partnered Products/ Combination Treatment Modalities, 2016 12
ProMetic Life Sciences Inc. - Phase III, 2016 13
ProMetic Life Sciences Inc. - Phase II, 2016 14
ProMetic Life Sciences Inc. - Phase I, 2016 15
ProMetic Life Sciences Inc. - Preclinical, 2016 16
ProMetic Life Sciences Inc. - Pipeline by Target, 2016 28
ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2016 29
ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2016 30
ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action, 2016 31
ProMetic Life Sciences Inc. - Recent Pipeline Updates, 2016 32
ProMetic Life Sciences Inc. - Dormant Developmental Projects,2016 38
ProMetic Life Sciences Inc., Other Locations 39
ProMetic Life Sciences Inc., Subsidiaries 40
List of Figures
ProMetic Life Sciences Inc. - Pipeline by Top 10 Indication, 2016 7
ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2016 9
ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2016 10
ProMetic Life Sciences Inc. - Pipeline by Target, 2016 28
ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2016 29
ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2016 30
ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action, 2016 31
